Rosetta Genomics Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Rosetta Genomics Ltd. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $43.75 per share as of 2016-12-31, per its 6-K filed 2017-10-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2017-10-10
- 2016-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $43.75.
- 2015-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $60.36; Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price as first filed $5.03.
- 2014-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $5.84.
- 2013-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $7.49.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2016-12-31 | $43.75 6-K · filed 2017-10-10 | |
| 2015-12-31 | $60.36 6-K · filed 2017-10-10 | $5.03 20-F · filed 2016-03-23 |
| 2014-12-31 | $5.84 6-K · filed 2016-12-08 | |
| 2013-12-31 | $7.49 20-F · filed 2015-03-16 | |
| 2012-12-31 | $10.64 20-F · filed 2014-03-31 | $13.19 20-F · filed 2013-03-22 |
| 2011-12-31 | $97.65 20-F · filed 2013-03-22 |